Extended Data Table 2 Grade 3 or Higher Toxicities with Possible or Higher Attribution to Surgery and/or Rickham Catheter while on Protocol Therapy

From: Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial